ZERO WORLD RESEARCHLiterature database on amino acids & organic acids

Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study.

Movement disorders : official journal of the Movement Disorder Society2011Altman RD, Lang AE, Postuma RB
Study designOther primary literature
SubjectHuman

Abstract

cc by 以外(cc by-nc / cc by-nc-nd / NONE 等)は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdultAgedAged, 80 and overCaffeineDose-Response Relationship, DrugHumansMiddle AgedParkinson DiseasePilot ProjectsPsychiatric Status Rating ScalesSeverity of Illness IndexTreatment Outcome

DOI 10.1002/mds.23873

PMID 21953603

View source →